This inventor holds 4 USPTO granted patents. Top assignee: Thomas Jefferson University. Active years: 1997-2002.
Company Filing History:
Years Active: 1997-2002
Title: The Innovations of Christian Sell
Introduction
Christian Sell is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of cellular biology. He holds four patents that focus on innovative methods for influencing cell proliferation and differentiation. His work is particularly relevant in the context of medical research and therapeutic applications.
Latest Patents
One of Sell's latest patents is titled "Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides." This method involves inhibiting the proliferation of undifferentiated cells by contacting them with an effective amount of an antisense oligonucleotide. The oligonucleotide sequence is designed to be complementary to specific regions of the IGF-1 receptor RNA, which plays a crucial role in cell signaling. The patent outlines the use of both oligodeoxynucleotide and oligoribonucleotide sequences, which may be delivered via an expression vector to achieve the desired cellular effects.
Career Highlights
Christian Sell is affiliated with Thomas Jefferson University, where he conducts research and develops his innovative methods. His work has garnered attention for its potential applications in regenerative medicine and cancer therapy. The focus on IGF-1 receptor pathways highlights the importance of targeted approaches in modern biomedical research.
Collaborations
Sell has collaborated with esteemed colleagues such as Renato L Baserga and Raphael Rubin. These collaborations have likely contributed to the depth and impact of his research, fostering an environment of innovation and discovery.
Conclusion
Christian Sell's contributions to the field of cellular biology through his patents and research at Thomas Jefferson University underscore the importance of innovation in medical science. His work continues to pave the way for advancements in therapeutic strategies aimed at cell differentiation and proliferation.